polatuzumab vedotin   Click here for help

GtoPdb Ligand ID: 8404

Synonyms: ACD79B-VCMMAE | polatuzumab vedotin-piiq | Polivy® | RG-7596 | RG7596 | RO5541077-000
Approved drug Immunopharmacology Ligand
polatuzumab vedotin is an approved drug (FDA (2019), EMA (2020))
Compound class: Antibody
Comment: Polatuzumab vedotin is an antibody drug conjugate containing an anti-CD79b monoclonal antibody linked to the toxin monomethyl auristatin E (MMAE, aka vedotin; PubChem CID 11542188).
Peptide sequence information for this antibody is available from its IMGT/mAb-DB record. Peptide sequence matches identify US8088378 as the claiming patent [1].
Classification Click here for help
Compound class Antibody
Approved drug? Yes (FDA (2019), EMA (2020))
International Nonproprietary Names Click here for help
INN number INN
9714 polatuzumab vedotin
Synonyms Click here for help
ACD79B-VCMMAE | polatuzumab vedotin-piiq | Polivy® | RG-7596 | RG7596 | RO5541077-000
Database Links Click here for help
GtoPdb PubChem SID 252166614
Search PubMed clinical trials polatuzumab vedotin
Search PubMed titles polatuzumab vedotin
Search PubMed titles/abstracts polatuzumab vedotin
Wikipedia Polatuzumab_vedotin